Name: SYKES & RAY EQUITIES (I) LTD.
Address: 3rd Floor, Cama Building, Dalal St, Kala Ghoda, Fort, Mumbai, 400001, IN
Telephone: 022 6193 7300

Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Bharat Immunological & Biologicals Corporation Ltd.

Apr 02 BSE 16.82 (+ 1.06 6.73%)

Volume37744

Prev. Close
15.76

Open Price
15.30

Today's Low / High

15.21 17.41

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

14.10 28.80

Bharat Immunological & Biologicals Corporation Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	431.80	431.80	431.80	431.80	431.80

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	43.18	43.18	43.18	43.18	43.18
Total Share Capital	43.18	43.18	43.18	43.18	43.18

Reserves and Surplus	44.62	62.17	-9.14	-22.71	-12.50
Total Reserves and Surplus	44.62	62.17	-9.14	-22.71	-12.50
Total Shareholders Funds	87.80	105.35	34.04	20.47	30.68

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.48
Long Term Provisions	6.42	6.11	5.85	5.65	5.33
Total Non-Current Liabilities	6.42	6.11	5.85	5.65	5.81

CURRENT LIABILITIES
Short Term Borrowings	70.22	77.89	27.29	3.04	32.22
Trade Payables	0.48	0.87	14.79	43.53	44.18
Other Current Liabilities	13.72	17.16	17.58	53.26	11.27
Short Term Provisions	7.02	5.35	4.42	0.88	0.80
Total Current Liabilities	91.44	101.26	64.09	100.71	88.48

Total Capital And Liabilities	185.66	212.73	103.99	126.83	124.96

ASSETS
NON-CURRENT ASSETS
Tangible Assets	115.33	84.08	4.23	4.47	4.70
Capital Work-In-Progress	0.00	31.90	31.90	0.22	0.22
Fixed Assets	115.33	115.98	36.13	4.68	4.92
Deferred Tax Assets [Net]	26.82	21.03	20.09	14.00	10.01
Other Non-Current Assets	10.44	10.29	13.81	15.13	11.30
Total Non-Current Assets	152.60	147.30	70.03	33.81	26.22


CURRENT ASSETS
Inventories	1.43	36.25	13.49	51.72	14.44
Trade Receivables	13.88	1.13	0.01	17.61	72.97
Cash And Cash Equivalents	8.74	13.01	10.54	12.10	7.93
OtherCurrentAssets	9.02	15.04	9.92	11.59	3.39
Total Current Assets	33.06	65.43	33.95	93.02	98.74

Total Assets	185.66	212.73	103.99	126.83	124.96

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.04	0.04	0.04	0.66

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	431.80

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	43.18
Total Share Capital	43.18
Reserves and Surplus	44.62
Total Reserves and Surplus	44.62
Total Shareholders Funds	87.80
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.00
Long Term Provisions	6.42
Total Non-Current Liabilities	6.42
CURRENT LIABILITIES
Short Term Borrowings	70.22
Trade Payables	0.48
Other Current Liabilities	13.72
Short Term Provisions	7.02
Total Current Liabilities	91.44
Total Capital And Liabilities	185.66
ASSETS
NON-CURRENT ASSETS
Tangible Assets	115.33
Capital Work-In-Progress	0.00
Fixed Assets	115.33
Deferred Tax Assets [Net]	26.82
Other Non-Current Assets	10.44
Total Non-Current Assets	152.60
CURRENT ASSETS
Inventories	1.43
Trade Receivables	13.88
Cash And Cash Equivalents	8.74
OtherCurrentAssets	9.02
Total Current Assets	33.06
Total Assets	185.66
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00